PSTV

#3614
PLUS THERAPEUTICS, Inc. Common Stock
0.30
0.00%
Сектор:
Базовая:
Валюта прибыли:
Дневной диапазон
0.30
0.30
Годовой диапазон
0.16
2.29
Дневное изменение
0.00%
Месячное изменение
+25.00%
6-месячное изменение
-40.00%
Годовое изменение
-55.88%
Предыдущее закрытие
0.30
Open
0.30
Bid
Ask
Low
0.30
High
0.30
Объем
7
Open full chart

Financials

Overview Отчетность Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Новости